• Download mobile app
17 Jan 2022, Edition - 2379, Monday

Trending Now

  • Kangana Ranaut had earlier approached the HC seeking that the FIR registered against her to be quashed.
  • Ghana to fine airlines $3,500 for unvaccinated passengers
  • Governor Arif Mohammed Khan junks Kerala CM Pinarayi Vijayan’s claims on VC postings
  • PM calls for free & open Indo-Pacific

Businesswire

Eurofins Announces Acquisition of Assets of Gomti Life Sciences

by businesswireindia.com

Share
Business Wire India
Eurofins, through Eurofins Advinus, acquires all assets of Gomti Life Sciences Private Limited through a Business Transfer Agreement. The assets include a fully equipped state-of-the-art manufacturing facility located in Bidadi Industrial Area, Bangalore, India, with cGMP pilot plant, intermediate area and ISO class 8 clean rooms and a total reactor capacity of about 45 KL. 

With this acquisition, Eurofins Advinus will be able to manufacture RSMs, intermediates, APIs and NCEs. The company can now support drug substance requirements from multi kilogram to MT scale for Toxicology studies, clinical trials and launch quantities.

Rajiv Malik, MD of Eurofins Advinus Limited commented: This acquisition could be a game changer for Eurofins Advinus as it enables the group to enter clinical development and commercial supply part of the Pharma R&D value chain through cGMP API supplies of NCEs. This addition is also a part of a larger foray of the Eurofins group into CDMO / CRAMS market.
Source: Businesswire